CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | Wu Xiaobin President, COO & GM China | Option exercise · Share Option (Right to Buy) 10b5-1 | −276,471 | 91,626 | ||
| 2025-02-18 | Wu Xiaobin President, COO & GM China | Option exercise 10b5-1 | +30,654 | $169.65 | $5.2M | 30,654 |
| 2025-02-18 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −19,576 | $240.31 | $4.7M | 11,078 |
| 2025-02-18 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −7,919 | $241.26 | $1.9M | 3,159 |
| 2025-02-18 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −3,159 | $242.08 | $765K | 0 |
| 2025-02-18 | Wu Xiaobin President, COO & GM China | Option exercise · Share Option (Right to Buy) 10b5-1 | −398,502 | 368,097 | ||
| 2025-02-04 | Wang Xiaodong Director | Option exercise 10b5-1 | +41,760 | $6.50 | $271K | 41,760 |
| 2025-02-04 | Wang Xiaodong Director | Sale 10b5-1 | −9,099 | $223.00 | $2.0M | 32,661 |
| 2025-02-04 | Wang Xiaodong Director | Sale 10b5-1 | −1,519 | $224.18 | $341K | 31,142 |
| 2025-02-04 | Wang Xiaodong Director | Sale 10b5-1 | −2,161 | $225.27 | $487K | 28,981 |
| 2025-02-04 | Wang Xiaodong Director | Sale 10b5-1 | −17,805 | $226.35 | $4.0M | 11,176 |
| 2025-02-04 | Wang Xiaodong Director | Sale 10b5-1 | −9,776 | $227.00 | $2.2M | 1,400 |
| 2025-02-04 | Wang Xiaodong Director | Sale 10b5-1 | −1,400 | $228.04 | $319K | 0 |
| 2025-02-04 | Wang Xiaodong Director | Option exercise · Share Option (Right to Buy) 10b5-1 | −542,880 | 2,171,527 | ||
| 2025-01-07 | Wang Xiaodong Director | Option exercise 10b5-1 | +41,760 | $6.50 | $271K | 41,760 |
| 2025-01-07 | Wang Xiaodong Director | Sale 10b5-1 | −19,251 | $175.46 | $3.4M | 22,509 |
| 2025-01-07 | Wang Xiaodong Director | Sale 10b5-1 | −11,310 | $176.67 | $2.0M | 11,199 |
| 2025-01-07 | Wang Xiaodong Director | Sale 10b5-1 | −4,260 | $177.42 | $756K | 6,939 |
| 2025-01-07 | Wang Xiaodong Director | Sale 10b5-1 | −5,638 | $178.39 | $1.0M | 1,301 |
| 2025-01-07 | Wang Xiaodong Director | Sale 10b5-1 | −1,301 | $179.18 | $233K | 0 |
Page 33 of 71 · 1,406 trades